Viewing Study NCT04650451

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-11 @ 8:34 PM
Study NCT ID: NCT04650451
Status: SUSPENDED
Last Update Posted: 2023-04-20
First Post: 2020-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Sponsor: Bellicum Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER-2 Gene Amplification View
None HER2-positive Gastric Cancer View
None HER2-positive Breast Cancer View
None HER-2 Protein Overexpression View
None Solid Tumor, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 View
None CAR-T View
None breast cancer View
None solid tumors View
None gastric cancer View